Literature DB >> 20345167

Group B oleanane triterpenoid extract containing soyasaponins I and III from soy flour induces apoptosis in Hep-G2 cells.

Wei Zhang1, David G Popovich.   

Abstract

Soyasaponins I and III are monodesmodic oleanane triterpenoids that are thought to be one of the main potentially bioactive saponins found in soy ( Glycine max ) and related products. An extract that contained a majority of the soyasaponins as I (62%) and III (29%) was studied in a hepatocarcinoma cell line (Hep-G2) to determine the potential cellular bioactivity. The extract was found to inhibit the growth of Hep-G2 cells measured by the MTT viability assay (LC50 0.389 +/- 0.02 mg/mL) dose-dependently. Cell death was determined using three distinct flow cytometry assays for apoptosis (sub-G1 cell-cycle analysis and multi-caspase and TUNEL assays), and cellular morphological images were acquired by confocal laser scanning microscopy. All of the apoptotic detection assays were positive for apoptotic cell accumulation. The TUNEL detection assay after 72 h of treatment showed the greatest apoptotic cell accumulation (40.45 +/- 4.95%), followed by the multi-caspase assay for 48 h treated cells (6.97 +/- 0.14% mid-apoptotic and 12.87 +/- 0.81% late apoptotic) and sub-G1 accumulation (17.67 +/- 0.42%). The multi-caspase assay indicated that the cellular protein expression of the caspase family of enzymes was the main apoptotic pathway trigger. Confocal laser scanning microscopy further confirmed the induction of apoptosis in Hep-G2 cells. Soyasaponins I and III may contribute to the reported bioactive and chemopreventative properties of soy by the induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345167     DOI: 10.1021/jf9037979

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  The effect of soymilk intake on the fecal microbiota, particularly Bifidobacterium species, and intestinal environment of healthy adults: a pilot study.

Authors:  Tomohiko Fujisawa; Yuji Ohashi; Ryoichi Shin; Asako Narai-Kanayama; Takenori Nakagaki
Journal:  Biosci Microbiota Food Health       Date:  2016-10-15

2.  Pharmacological Approaches to Attenuate Inflammation and Obesity with Natural Products Formulations by Regulating the Associated Promoting Molecular Signaling Pathways.

Authors:  Muhammad Imran Khan; Muhammad Zubair Khan; Jin Hyuk Shin; Tia Sun Shin; Young Bok Lee; Min Yung Kim; Jong Deog Kim
Journal:  Biomed Res Int       Date:  2021-11-12       Impact factor: 3.411

3.  Anti-Colon Cancer Activity of Dietary Phytochemical Soyasaponin I and the Induction of Metabolic Shifts in HCT116.

Authors:  Xuewei Xia; Qianmin Lin; Ning Zhao; Jinzi Zeng; Jiajia Yang; Zhiyuan Liu; Riming Huang
Journal:  Molecules       Date:  2022-07-08       Impact factor: 4.927

4.  The content of soyasaponin and soyasapogenol in soy foods and their estimated intake in the Japanese.

Authors:  Shuichi Kamo; Shunsuke Suzuki; Toshiro Sato
Journal:  Food Sci Nutr       Date:  2014-03-30       Impact factor: 2.863

5.  Saponins and Flavonoids from Adzuki Bean (Vigna angularis L.) Ameliorate High-Fat Diet-Induced Obesity in ICR Mice.

Authors:  Rui Liu; Yinan Zheng; Zongwei Cai; Baojun Xu
Journal:  Front Pharmacol       Date:  2017-09-27       Impact factor: 5.810

6.  MALDI-Mass Spectrometry Imaging to Investigate Lipid and Bile Acid Modifications Caused by Lentil Extract Used as a Potential Hypocholesterolemic Treatment.

Authors:  Michele Genangeli; Annemarie M M Heijens; Alice Rustichelli; Noortje Dien Schuit; Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Sauro Vittori; Tiffany Porta Siegel; Ron M A Heeren
Journal:  J Am Soc Mass Spectrom       Date:  2019-08-05       Impact factor: 3.109

7.  Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells.

Authors:  Amr Omar; Rajkumar Singh Kalra; Jayarani Putri; Ahmed Elwakeel; Sunil C Kaul; Renu Wadhwa
Journal:  Sci Rep       Date:  2020-04-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.